MACI: Clinical Trials

3 trials of MACI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Recruiting 1

Follow MACI: new trials by email Literature Review of MACI trials Research Report on MACI

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
MACI, microfracture - Chondral Defect, Osteochondritis Dissecans (OCD)
Phase 3RecruitingVericel Corporation452018-10-242026-11-03
Extension Study for Participants of MACI00206 Study of MACI® for the Treatment of Symptomatic Articular Cartilage Defects of the Knee
autologous cultured chondrocytes on porcine collagen membrane, Microfracture - Articular Cartilage Defects
CompletedVericel Corporation1282010-12-012021-05-12
Superiority of MACI® Versus Microfracture Treatment in Patients With Symptomatic Articular Cartilage Defects in the Knee
autologous cultured chondrocytes on porcine collagen membrane, Microfracture - Articular Cartilage Defect
Phase 3CompletedVericel Corporation1442008-07-012021-05-12

Conditions studied

Fractures, Stress (2)  ·  Osteochondritis Dissecans (1)

Sponsors

Vericel Corporation (3)

Countries

Czechia (2)  ·  France (2)  ·  Netherlands (2)  ·  Norway (2)  ·  Poland (2)  ·  Sweden (2)  ·  United Kingdom (2)  ·  United States (1)

Top investigators

Jonathan Hopper, BSc (Hons), MB ChB, FRCSEd (1)

Results publications

PMID 24714783

NIH funding

2009 (1)